Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Recurrence × selinexor × Clear all

Phase

Phase 2 7 Phase 1/2 5 Phase 3 4 Phase NA 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 10 Sarcoma 5 Multiple Myeloma 5 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neurofibrosarcoma 2 Myelodysplastic Syndromes 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Glioblastoma 2 Congenital Abnormalities 2 Colorectal Neoplasms 2 Central Nervous System Neoplasms 2 Waldenstrom Macroglobulinemia 1 Solid Tumors 1 Sarcoma, Ewing 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Rhabdoid Tumor 1 Recurrence 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 39 fludarabine 28 Dexamethasone 20 venetoclax 19 Cytarabine 16 Rituximab 13 pembrolizumab 12 fludarabine phosphate 12 Filgrastim 12 Gemcitabine 10 Etoposide 10 Granulocyte Colony-Stimulating Factor 9 carfilzomib 8 Vincristine 8 Topotecan 8 Interleukin-2 8 Decitabine 8 Nivolumab 7 Melphalan 7 Lenalidomide 7 Everolimus 7 Doxorubicin 7 Azacitidine 7 pomalidomide 6 Vorinostat 6 Carboplatin 6 Calcium Dobesilate 6 Bortezomib 6 obinutuzumab 5 ibrutinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03661515 2020-05-20

FLAGINEXOR

PETHEMA Foundation

Phase 1 Completed

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡